Literature DB >> 33899786

Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung.

Abbas Agaimy1, Robert Stoehr, Michael Michal, Petros Christopoulos, Hauke Winter, Lei Zhang, Albrecht Stenzinger, Michal Michal, Gunhild Mechtersheimer, Cristina R Antonescu.   

Abstract

Clear cell (hemangioblastoma-like) stromal tumor of the lung (CCST-L) is a recently described distinctive rare pulmonary neoplasm of unknown histogenesis and molecular pathogenesis. Only 7 cases have been reported in 2 recent studies, although additional cases might have been reported under the heading of extraneural pulmonary hemangioblastoma. We herein describe 4 CCST-L cases, 3 of them harboring a YAP1-TFE3 fusion. The fusion-positive tumors occurred in 3 women, aged 29, 56, and 69 years. All presented with solitary lung nodules measuring 2.3 to 9.5 cm. Histologically, all tumors showed similar features being composed of relatively uniform medium-sized epithelioid to ovoid cells with clear cytoplasm and small round monomorphic nuclei. Scattered larger cells with enlarged hyperchromatic nuclei and marked pleomorphism were noted in 2 cases. The tumors were associated with a hypervascularized stroma with variable but essentially subtle resemblance to capillary hemangioblastoma and perivascular epithelioid cell tumor (PEComa). Immunohistochemistry was negative for all lineage-specific markers. Targeted RNA sequencing showed a YAP1-TFE3 fusion in 3 of 4 cases. All 3 tumors showed homogeneous nuclear TFE3 immunoreactivity. Two patients were disease free at 36 and 12 months. The third patient had biopsy-proven synchronous renal and hepatic metastases, but extended follow-up is not available (recent case). The fourth case lacking the fusion affected a 66-year-old woman and showed subtle histologic differences from the fusion-positive cases, but had comparable TFE3 immunoreactivity. CCST-L represents a distinctive entity unrelated to hemangioblastoma and likely driven by recurrent YAP1-TFE3 fusions in most cases. The relationship of our cases to the recently reported "hemangioblastoma-like" CCST-L remains to be determined. Analysis of larger series is paramount to delineate the morphologic spectrum and biological behavior of this poorly characterized entity.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33899786     DOI: 10.1097/PAS.0000000000001719

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  3 in total

1.  PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia.

Authors:  Pedram Argani; Sara E Wobker; John M Gross; Andres Matoso; Christopher D M Fletcher; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2022-04-05       Impact factor: 6.298

Review 2.  Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma.

Authors:  Caleb N Seavey; Ajaybabu V Pobbati; Brian P Rubin
Journal:  Cancers (Basel)       Date:  2022-06-16       Impact factor: 6.575

3.  Case Report: Hemangioblastoma- Like Clear Cell Stromal Tumor of the Left Lower Lung.

Authors:  Xiaowei Zhang; Bifei Huang; Hongquan Jiang; Hangping Wei
Journal:  Front Med (Lausanne)       Date:  2022-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.